We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $8.17B
1-Year Est. Return 68.82%
This Fund
S&P 500
This Quarter Est. Return
+1.37%
1 Year Est. Return
+68.82%
3 Year Est. Return
+79.68%
5 Year Est. Return
+64.24%
10 Year Est. Return
+259.8%
AUM
$5.76B
AUM Growth
+$32.7M
Cap. Flow
+$188M
Cap. Flow %
3.27%
Top 10 Hldgs %
50.49%
Holding
248
New
70
Increased
46
Reduced
39
Closed
50

Top Buys

Rank Stock Value
1
GSK icon
GSK
GSK
+$136M
2
FRPT icon
Freshpet
FRPT
+$91.3M
3
ROST icon
Ross Stores
ROST
+$81.3M
4
FIVE icon
Five Below
FIVE
+$72.6M
5
EXAS
Exact Sciences
EXAS
+$64.3M

Top Sells

Rank Stock Value
1
DG icon
Dollar General
DG
+$75.6M
2
CPRX
Catalyst Pharmaceutical
CPRX
+$71.5M
3
ILMN icon
Illumina
ILMN
+$62.5M
4
AZN icon
AstraZeneca
AZN
+$55.2M
5
TSCO icon
Tractor Supply
TSCO
+$51.8M

Sector Composition

Rank Sector Weight
1 Healthcare 43.48%
2 Miscellaneous 31.17%
3 Consumer Discretionary 9.47%
4 Consumer Staples 8.21%
5 Technology 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TCBPW
151
DELISTED
TC BioPharm (Holdings) plc Warrants
TCBPW
$435K 0.01%
1,882,352
– –
SKYAW
152
SkyAI Inc
SKYAW
$287K
$413K 0.01%
1,176,000
– –
FGIWW
153
FGI Industries Warrant
FGIWW
$375K 0.01%
933,333
– –
SBEV.WS
154
DELISTED
Splash Beverage Group, Inc. Warrants to purchase 1/40th of a share of Common Stock at an exercise price of $184.00
SBEV.WS
$371K 0.01%
904,000
– –
SNAX
155
DELISTED
Stryve Foods, Inc. Class A Common Stock
SNAX
$352K 0.01%
44,260
-36,876
-45% -$409K
YYAI icon
156
AiRWA Inc
YYAI
$43.7K
– –
0
– –
TENX icon
157
Tenax Therapeutics
TENX
$74.5M
$334K 0.01%
1,229
+231
+23% +$92.7K
BEATW icon
158
Heartbeam Inc Warrant
BEATW
$27.5K
$295K 0.01%
500,000
– –
ERNA icon
159
Eterna Therapeutics
ERNA
$4.88M
$274K ﹤0.01%
148
-431
-74% -$1.49M
ADXN
160
Addex Therapeutics
ADXN
$4.63M
$256K ﹤0.01%
16,000
+3,349
+26% +$74.9K
DRCTW
161
DELISTED
Direct Digital Holdings, Inc. Warrant
DRCTW
$243K ﹤0.01%
900,000
– –
AREB
162
DELISTED
American Rebel
AREB
– –
0
– –
MTEKW icon
163
Maris-Tech Ltd Warrants
MTEKW
$211K ﹤0.01%
1,261,058
– –
ACONW icon
164
Aclarion Warrant
ACONW
$51.2K
$209K ﹤0.01%
550,000
– –
GMBLZ
165
DELISTED
Esports Entertainment Group Inc. Warrant
GMBLZ
$189K ﹤0.01%
2,700,000
– –
GROY.WS
166
DELISTED
Gold Royalty Corp. Warrants, each warrant exercisable for one common share at an exercise price of $7.50
GROY.WS
$168K ﹤0.01%
448,000
– –
NXGLW icon
167
NexGel Inc Warrant
NXGLW
$25.8K
$165K ﹤0.01%
550,000
– –
BRSHW
168
DELISTED
Bruush Oral Care Inc. Warrant
BRSHW
$163K ﹤0.01%
+600,962
New +$277K
KTTAW icon
169
Pasithea Therapeutics Warrants
KTTAW
$148K ﹤0.01%
1,000,000
– –
SWAGW icon
170
Stran & Company Warrant
SWAGW
$23.9K
$142K ﹤0.01%
545,000
– –
GMVDW
171
DELISTED
G Medical Innovations Holdings Ltd. Warrants
GMVDW
$140K ﹤0.01%
1,000,000
– –
AGRIW
172
DELISTED
AgriFORCE Growing Systems Ltd Warrant
AGRIW
$129K ﹤0.01%
600,000
– –
MDGSW
173
DELISTED
Medigus Ltd. Series C Warrant
MDGSW
$129K ﹤0.01%
1,285,715
– –
NLSPW
174
DELISTED
NLS Pharmaceutics Warrant
NLSPW
$125K ﹤0.01%
500,000
– –
HSCSW icon
175
HeartSciences Inc Warrant
HSCSW
$150K
$109K ﹤0.01%
352,941
– –
5 6
7
8 9

Similar funds

MWM
Mission Wealth Management Santa Barbara, California $8.18B AUM 28.28% 1-Year Est. Return
BP
Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return
SC
Saturna Capital Bellingham, Washington $8.19B AUM 42.01% 1-Year Est. Return
SFM
Soros Fund Management New York $8.14B AUM 35.85% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
BIM
Bridges Investment Management Omaha, Nebraska $8.22B AUM 21.38% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return

Armistice Capital's Q3 2022 Portfolio in Review

As of Q3 2022, Armistice Capital held 248 positions worth $5.76B, up 0.57% from $5.73B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Armistice Capital deployed $188M of net new capital in Q3 2022, opening 70 new positions and adding to 46 existing holdings. Its largest new stake was GSK: 3,600,000 shares worth $106M.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 44% a quarter earlier, followed by Miscellaneous and Consumer Discretionary.

On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $46.6M trimmed.

  • Armistice Capital's largest Q3 2022 buy was GSK: 3,600,000 shares worth $106M.
  • Armistice Capital added most to Freshpet in Q3 2022, an estimated $91.3M increase.
  • Armistice Capital's biggest Q3 2022 reduction was Vertex Pharmaceuticals, cutting an estimated $46.6M.
  • Armistice Capital fully exited Dollar General in Q3 2022, selling an estimated $75.6M.
  • Armistice Capital's ten largest holdings make up 50% of its $5.76B portfolio in Q3 2022.
  • Armistice Capital opened 70 new positions and closed 50 in Q3 2022.
  • Armistice Capital's portfolio value rose 0.57% quarter-over-quarter to $5.76B.

Based on Armistice Capital's 13F filing for Q3 2022, filed 14 Nov 2022.